Corporate Governance - Highlights

Aduro is a cancer immunotherapy company developing products designed to ignite or regulate the immune system. Aduro’s technologies are uniquely positioned to cover the cancer-immunity cycle: immune checkpoint inhibition and targeting the tumor microenvironment.